Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study

scientific article (publication date: 7 July 2010)

Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study is …
instance of (P31):
scholarly articleQ13442814

External links are
P5530Altmetric DOI10.1136/BMJ.C2701
P6409CORE ID185458530
P6179Dimensions Publication ID1010032747
P356DOI10.1136/BMJ.C2701
P953full work available at URLhttp://eprints.whiterose.ac.uk/81087
P3181OpenCitations bibliographic resource ID1926812
P932PMC publication ID2898925
P698PubMed publication ID20610512

P50authorPaul StewartQ42887432
Saaeha RauzQ51793723
Alexandra J. SinclairQ54255687
Jeremy W TomlinsonQ61267776
Carl E ClarkeQ63919326
Michael A BurdonQ114778985
Mark LawdenQ114778986
P2093author name stringPeter Good
Elizabeth A Walker
Alexandra K Ball
Peter G Nightingale
Timothy D Matthews
Andrew Jacks
P2860cites workInterventions for idiopathic intracranial hypertensionQ24246672
Swelling of the optic nerve head: a staging schemeQ24561732
Perioperative safety in the longitudinal assessment of bariatric surgeryQ24594848
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydratesQ24652265
Randomized, controlled trials, observational studies, and the hierarchy of research designsQ24670544
Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatmentQ28222006
Ultrasonographic evaluation of optic disc swelling: comparison with CSLO in idiopathic intracranial hypertensionQ30914383
Topiramate: a review of preclinical, pharmacokinetic, and clinical dataQ32135911
Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomographyQ33384584
Diagnostic criteria for idiopathic intracranial hypertensionQ34161245
Meta-analysis: pharmacologic treatment of obesityQ34408897
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label studyQ34699512
Exploring the pathogenesis of IIH: an inflammatory perspectiveQ37233835
Effects of weight loss on the course of idiopathic intracranial hypertension in womenQ41753662
Headache Impact Test-6 (HIT-6) scores for migraine patients: Their relation to disability as measured from a headache diaryQ43122196
Withdrawal of sibutramine in EuropeQ43166872
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissueQ44924302
Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesityQ45082819
Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophiliaQ45300087
The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)Q47274308
Ventriculoperitoneal shunting for idiopathic intracranial hypertension.Q51600700
Learning effect of standard automated perimetry in healthy individuals.Q51949120
A six-item short-form survey for measuring headache impact: the HIT-6.Q53363511
Pseudotumor cerebri treated by rice reduction diet.Q54217550
CSF opening pressure: Reference interval and the effect of body mass indexQ57384713
Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual lossQ70422189
[The new IHS classification. Background and structure]Q80530851
P433issuejul07 2
P407language of work or nameEnglishQ1860
P921main subjectarterial hypertensionQ41861
idiopathyQ594841
intracranial hypertensionQ18558125
P304page(s)c2701
P577publication date2010-07-07
P1433published inThe BMJQ546003
P1476titleLow energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study
P478volume341

Reverse relations

cites work (P2860)
Q9958553311β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
Q42584276A 6-month telephone-based weight loss intervention in overweight and obese subjects with idiopathic intracranial hypertension
Q47660883A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus.
Q34608944A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension.
Q39805081A randomised controlled trial of treatment for idiopathic intracranial hypertension
Q64066377A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics
Q37710832Acute headache
Q90474190Advances in the understanding of headache in idiopathic intracranial hypertension
Q91938775Are CSF Pressure Factors Related to the Development of Post-dural Puncture Headache?
Q42369171Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.
Q91701623Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom
Q37587255Bariatric Surgery or Non-surgical Weight Loss for Idiopathic Intracranial Hypertension? A Systematic Review and Comparison of Meta-analyses.
Q34249708Cerebrospinal fluid and lumbar puncture: a practical review
Q51084496Choroid plexus aquaporin 1 and intracranial pressure are increased in obese rats: towards an idiopathic intracranial hypertension model?
Q57985150Diet and nutraceutical interventions for headache management: A review of the evidence
Q91690662Endovascular Treatment for Venous Sinus Stenosis in Idiopathic Intracranial Hypertension: An Observational Study of Clinical Indications, Surgical Technique, and Long-Term Outcomes
Q57294841European headache federation guideline on idiopathic intracranial hypertension
Q51736876Evaluating the Fat Distribution in Idiopathic Intracranial Hypertension Using Dual-Energy X-ray Absorptiometry Scanning.
Q64944879Evaluation and management of adult idiopathic intracranial hypertension.
Q26765034Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
Q89538775Exploring The Current Management Idiopathic Intracranial Hypertension, And Understanding The Role Of Dural Venous Sinus Stenting
Q35041025Formula food-reducing diets:A new evidence-based addition to the weight management tool box.
Q92381080Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension
Q38236305Headache and the pseudotumor cerebri syndrome
Q37860205Headache attributable to nonvascular intracranial disorders
Q35620869Headache determines quality of life in idiopathic intracranial hypertension.
Q38061011High-pressure headaches: idiopathic intracranial hypertension and its mimics
Q41528844Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management.
Q56060083Idiopathic intracranial hypertension
Q36561779Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management
Q90488399Idiopathic intracranial hypertension and bariatric surgery: a systematic review
Q31155124Idiopathic intracranial hypertension in children: Diagnostic and management approach
Q53196140Idiopathic intracranial hypertension is not benign: a long-term outcome study.
Q26749288Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases
Q89108010Idiopathic intracranial hypertension: consensus guidelines on management
Q38148469Idiopathic intracranial hypertension; research progress and emerging themes.
Q50110442Indications and technique for transconjunctival optic nerve sheath fenestration : Video article
Q47289520Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).
Q24187976Interventions for idiopathic intracranial hypertension
Q47980503Intracranial hypertension induced by internal jugular vein stenosis can be resolved by stenting.
Q37941981Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review
Q41626158Long-term Response of Cerebrospinal Fluid Pressure in Patients with Idiopathic Intracranial Hypertension - A Prospective Observational Study
Q53200381Lumbopleural Shunting as an Alternative Cerebrospinal Fluid Diversion Modality for Management of Idiopathic Intracranial Hypertension: Is It Time for a Change?
Q89474410Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
Q56604602Neurophysiologic tests screening cognitive impairment in idiopathic intracranial hypertension patients
Q92324773Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
Q37684467Obesity and headache: Part II--potential mechanism and treatment considerations.
Q92275655Obesity, Ethnicity and Idiopathic Intracranial Hypertension
Q48113865Ocular ultrasound for monitoring pseudotumor cerebri syndrome.
Q47815168Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension
Q36383569Over-drainage and persistent shunt-dependency in patients with idiopathic intracranial hypertension treated with shunts and bariatric surgery
Q37987064Papilledema: are we any nearer to a consensus on pathogenesis and treatment?
Q33585419Papilledema: epidemiology, etiology, and clinical management
Q50021120Pediatric Intracranial Hypertension: a Current Literature Review
Q88271180Perspectives on diagnosis and management of adult idiopathic intracranial hypertension
Q88798671Pseudotumor Cerebri Syndrome with Resolution After Discontinuing High Vitamin A Containing Dietary Supplement: Case Report and Review
Q34780008Pseudotumor cerebri: an update on treatment options
Q41947767Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol
Q61628181Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension
Q46949609Reevaluation of presentation and course of idiopathic intracranial hypertension--a large cohort comprehensive study
Q36997244Risperidone Induced Benign Intracranial Hypertension Leading to Visual Loss
Q83978747Sonographic assessment of the optic nerve sheath in idiopathic intracranial hypertension
Q26745691The diagnosis and management of idiopathic intracranial hypertension and the associated headache
Q57791445The expanding burden of idiopathic intracranial hypertension
Q37855973The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK.
Q89092175Topiramate is more effective than acetazolamide at lowering intracranial pressure
Q38678284Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions.
Q55059941Update on Idiopathic Intracranial Hypertension.
Q35126814Update on idiopathic intracranial hypertension
Q36529652Update on the pathophysiology and management of idiopathic intracranial hypertension
Q37439414Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension
Q53670852[Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension].
Q89916883[Idiopathic intracranial hypertension]
Q52877452[Pseudotumor cerebri syndrome].

Search more.